Evidence map›Paper›PMID 40032727›Full record

ArticleGut microbes2025

Cristina Santiso-Bellón, Walter Randazzo, Noelia Carmona-Vicente, Nazaret Peña-Gil, Roberto Cárcamo-Calvo, Sergi Lopez-Navarro, Noemi Navarro-Lleó, Maria J Yebra, Vicente Monedero, Javier Buesa and 2 more

Abstract read
In one paragraph

Article in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Extracellular Polymeric Substances Produced by Actinomycetes of the GenusInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cristina Santiso-BellónDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-1698-5062
Walter RandazzoDepartamento de Conservación y Seguridad Alimentaria, Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Valencia, Spain.ORCID 0000-0002-7433-149X
Noelia Carmona-VicenteDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.
Nazaret Peña-GilDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-3553-4582
Roberto Cárcamo-CalvoDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-4753-7406
Sergi Lopez-NavarroDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0002-1893-2776
Noemi Navarro-LleóDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-2572-9220
Maria J YebraDepartamento de Biotecnología de Alimentos, Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Valencia, Spain.ORCID 0000-0003-4638-986X
Vicente MonederoDepartamento de Biotecnología de Alimentos, Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Valencia, Spain.ORCID 0000-0001-7461-8047
Javier BuesaDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0002-3328-3428
Roberto Gozalbo-RoviraDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-3427-3800
Jesús Rodríguez-DíazDepartamento de Microbiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0002-9698-7684

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections, particularly human norovirus (NoV), are a leading cause of diarrheal diseases globally. To better understand NoV susceptibility, it is crucial to investigate both host glycobiology and the influence of the microbiota. Histo-blood group antigens (HBGA) displayed on surfaces of host cells act as NoV receptors, while certain bacteria express HBGA-like substances, facilitating virus-bacteria interactions. To identify bacterial species interacting with NoV during infection, stool samples from children infected with NoV GII.4 were analyzed. The samples were subjected to bacteria separation using anti-NoV GII.4 polyclonal antibodies coupled to magnetic beads, followed by microbiota profiling through 16S rDNA sequencing. This approach identified the genus

Indexed as

Caliciviridae InfectionsNorovirusRhodococcusVirus ReplicationBlood Group AntigensChildFecesGastrointestinal MicrobiomeHumansIntestinesPolysaccharides, BacterialBlood Group AntigensPolysaccharides, Bacterialgut microbiotahisto-blood group antigenshuman intestinal enteroidsHuman norovirusRhodococcusstool samples

Identifiers

PMID40032727
PMCPMC11881836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.